As increasingly complex, poorly water-soluble molecules enter development, AustinPx helps developers look beyond near-term ...
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor. PhD, AbbVie, and Swita Singh, PhD, Bristol ...
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor. PhD, AbbVie, and Swita Singh, PhD, Bristol ...
Robert Holt, PhD, associate director, Pharmaceutical Science, digiM Solution, discusses microstructure intelligence in more ...
Novartis obtained portfolio-level options for exclusive rights to Hybrozyme-enabled SC formulations, with economics up to ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
Ryan Swanson | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
The finalists for the 2026 CPHI Pharma Awards span15 categories including API development, digital transformation, ...
Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved. In ...
On August 31, 2026, Eli Lilly announced it has entered a definitive agreement to acquire Merida Biosciences, a biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results